Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Grifols S.A. ADR (GRFS)

Grifols S.A. ADR (GRFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,187,995
  • Shares Outstanding, K 687,555
  • Annual Sales, $ 5,836 M
  • Annual Income, $ 223,280 K
  • 60-Month Beta 0.28
  • Price/Sales 1.06
  • Price/Cash Flow 8.85
  • Price/Book 0.69
Trade GRFS with:

Options Overview Details

View History
  • Implied Volatility 106.50% ( +16.87%)
  • Historical Volatility 58.96%
  • IV Percentile 98%
  • IV Rank 88.97%
  • IV High 115.93% on 05/09/22
  • IV Low 30.42% on 10/13/21
  • Put/Call Vol Ratio 0.10
  • Today's Volume 23
  • Volume Avg (30-Day) 221
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 5,204
  • Open Int (30-Day) 3,409

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.28 +8.63%
on 08/02/22
10.72 -16.04%
on 07/26/22
-1.57 (-14.85%)
since 07/12/22
3-Month
8.28 +8.63%
on 08/02/22
13.34 -32.53%
on 05/24/22
-3.52 (-28.12%)
since 05/12/22
52-Week
8.28 +8.63%
on 08/02/22
15.90 -43.40%
on 09/27/21
-5.29 (-37.02%)
since 08/12/21

Most Recent Stories

More News
Kepler Capital Sticks to Its Hold Rating for Grifols SA (GRFS)

Kepler Capital analyst Dariusz Ubik maintained a Hold rating on Grifols SA (GRFS – Research Report) on July 1 and set a price target of EUR22.90. The company's shares closed last Friday at $12.49. According...

GRFS : 9.00 (+0.22%)
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

These three healthcare stocks should hold their value for years.

BAYRY : 13.9100 (+4.35%)
TAK : 14.25 (+0.92%)
GRFS : 9.00 (+0.22%)
Illumina Ventures Announces Promotion and Additions to its Investment Team

Illumina Ventures , today announced the promotion of Malek Faham, MD, PhD, to Chief Scientist having previously served as both a Venture Partner and Entrepreneur in Residence (EIR). In addition, Charles...

ADPT : 12.32 (+1.65%)
AFFX : 14.01 (+0.14%)
CSTL : 33.94 (-0.79%)
GRFS : 9.00 (+0.22%)
NTRA : 55.17 (+2.95%)
ILMN : 208.32 (-8.40%)
The Best Healthcare Dividend Stock on the Planet for Generating Passive Income

This REIT has it all.

MPW : 16.72 (+2.45%)
GRFS : 9.00 (+0.22%)
OHI : 33.56 (+1.39%)
NHI : 66.16 (+2.05%)
2 Healthcare Stocks That Could Help Make You a Fortune

Their dividends will be trickling into your account quarter after quarter.

GRFS : 9.00 (+0.22%)
BMY : 75.57 (+1.49%)
New Strong Sell Stocks for January 6th

CPSI, GRFS, LE, and NESR have been added to the Zacks Rank #5 (Strong Sell) List on January 6, 2022

GRFS : 9.00 (+0.22%)
CPSI : 31.28 (+2.62%)
LE : 16.12 (+1.70%)
NESR : 6.87 (-1.72%)
Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines

/PRNewswire/ -- Grifols (MCE:GRF) (MCE:GRF.P) (NASDAQ:GRFS), one of the world's leading producers of plasma-derived medicines with a more than 110-year track...

GRFS : 9.00 (+0.22%)
GRF : 8.94 (-1.76%)
GigaGen Licenses ProteoNic’s 2G UNicTM Technology Platform for High Yield Production of GigaGen’s Mono- and Polyclonal Antibody Drug Candidates

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- GigaGen Inc. , a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint...

GRF : 8.94 (-1.76%)
GRFS : 9.00 (+0.22%)
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 for COVID-19

First-in-human study evaluating recombinant hyperimmunes

GRF : 8.94 (-1.76%)
GRFS : 9.00 (+0.22%)
Alkahest Strengthens Management Team with Addition of César Cerezo as Chief Medical Officer

SAN CARLOS, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical-stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases...

GRF : 8.94 (-1.76%)
GRFS : 9.00 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience...

See More

Key Turning Points

3rd Resistance Point 9.15
2nd Resistance Point 9.11
1st Resistance Point 9.05
Last Price 9.00
1st Support Level 8.95
2nd Support Level 8.91
3rd Support Level 8.85

See More

52-Week High 15.90
Fibonacci 61.8% 12.99
Fibonacci 50% 12.09
Fibonacci 38.2% 11.19
Last Price 9.00
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar